Sugi Predict

Sugi Predict / Compounds / SCHEMBL735471

SCHEMBL735471

SCHEMBL735471

CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SHBG P04278 6/20 1.00
▸ CYP17A1 P05093 5/20 0.73
▸ ALDH1A1 P00352 1/20 0.70
▸ CYP2C9 P11712 1/20 0.70
▸ HIF1A Q16665 1/20 0.70
▸ G6PD P11413 4/20 0.61
▸ LMNA P02545 3/20 0.61
▸ SERPINA6 P08185 3/20 0.61
▸ MEN1 O00255 1/20 0.61
▸ GUSB P08236 1/20 0.61
▸ CYP3A4 P08684 1/20 0.61
▸ PMP22 Q01453 1/20 0.61
▸ KMT2A Q03164 1/20 0.61
▸ GPBAR1 Q8TDU6 1/20 0.61
▸ TSHR P16473 1/20 0.61
▸ SMN1; SMN2 Q16637 1/20 0.61
▸ ESR1 P03372 1/20 0.58
▸ AR P10275 1/20 0.58
▸ ESR2 Q92731 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17776491 1.00 SHBG (1.00) SHBGCYP17A1ALDH1A1CYP2C9HIF1A
SCHEMBL138937 1.00 SHBG (1.00) SHBGCYP17A1ALDH1A1CYP2C9HIF1A
SCHEMBL142941 1.00 SHBG (1.00) SHBGCYP17A1ALDH1A1CYP2C9HIF1A
SCHEMBL27808104 1.00 SHBG (1.00) SHBGCYP17A1ALDH1A1CYP2C9HIF1A
SCHEMBL658688 1.00 SHBG (1.00) SHBGCYP17A1ALDH1A1CYP2C9HIF1A
SCHEMBL18373712 1.00 SHBG (1.00) SHBGCYP17A1ALDH1A1CYP2C9HIF1A
SCHEMBL20457510 1.00 SHBG (1.00) SHBGCYP17A1ALDH1A1CYP2C9HIF1A
SCHEMBL27633183 1.00 SHBG (1.00) SHBGCYP17A1ALDH1A1CYP2C9HIF1A
Sulfuric Acid SCHEMBL1576876 0.96 SHBG (0.91) SHBGCYP17A1ALDH1A1CYP2C9HIF1A
SCHEMBL31086698 0.92 SHBG (0.85) SHBGCYP17A1ALDH1A1CYP2C9HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 566 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4740024-A1 ENDOMETRIOSIS MARKERS AND METHODS OF DIAGNOSING ENDOMETRIOSIS The University Court Of The University of Edinburgh (GB) 2026-05-13 — — EP claimed
EP-4718073-A2 MASS SPECTROMETRY ASSAY FOR CONGENITAL ADRENAL HYPERPLASIA Quest Diagnostics Investments Incorporated (US) 2026-04-01 — — EP claimed
EP-4718074-A2 MASS SPECTROMETRY ASSAY FOR CONGENITAL ADRENAL HYPERPLASIA Quest Diagnostics Investments Incorporated (US) 2026-04-01 — — EP claimed
US-20250279209-A1 PROVISION OF A MEDICAL RISK ASSESSMENT FOR NONCLASSICAL 21-HYDROXYLASE DEFICIENCY UNIV SORBONNE (FR) 2025-09-04 — — US claimed
EP-3486648-B1 MASS SPECTROMETRY ASSAY FOR CONGENITAL ADRENAL HYPERPLASIA QUEST DIAGNOSTICS INVEST INC (US) 2025-04-30 — — EP claimed
CN-119643736-A Novel method for detecting 23-steroid substances in different matrixes by using solid-phase extraction column 大连海事大学 2025-03-18 — — CN claimed
EP-4511660-A1 PROVISION OF A MEDICAL RISK ASSESSMENT FOR NONCLASSICAL 21-HYDROXYLASE DEFICIENCY SORBONNE UNIVERSITE (FR) 2025-02-26 — — EP claimed
WO-2025008638-A1 ENDOMETRIOSIS MARKERS AND METHODS OF DIAGNOSING ENDOMETRIOSIS THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) 2025-01-09 — — WO claimed
EP-4484959-A2 MASS SPECTROMETRY ASSAY FOR CONGENITAL ADRENAL HYPERPLASIA Quest Diagnostics Investments Incorporated (US) 2025-01-01 — — EP claimed
CN-117849228-A Biomarker for screening early sexual precocity and application thereof 裕菁科技(上海)有限公司 2024-04-09 — — CN claimed
US-20010044430-A1 Cosmetic composition containing a steroid and a 2-alkylalkanol or an ester thereof L'OREAL (FR) 2001-11-22 — — US claimed
WO-2001088548-A1 ADRENAL DYSFUNCTION MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2001-11-22 — — WO claimed
US-20010012630-A1 Yeast strains possessing the interrupted ATF2 gene and their applications HOECHST MARION ROUSSEL 2001-08-09 — — US claimed
US-6218139-B1 MODIFIED YEAST STRAIN WITH ACETYL-COENZYME A PREGNENOLONE ACETYLTRANSFERASE ELIMINATED, RESULTING IN STABILIZATION OF BETA-HYDROXY STEROIDS HOECHST MARION ROUSSEL (FR) 2001-04-17 — — US claimed
EP-0977868-A1 YEAST STRAINS WITH INTERRUPTED ATF2 GENE AND USES HOECHST MARION ROUSSEL (FR) 2000-02-09 — — EP claimed
WO-1999040203-A1 YEAST STRAINS WITH INTERRUPTED ATF2 GENE AND USES HOECHST MARION ROUSSEL (FR) 1999-08-12 — — WO claimed
EP-0649472-A4 FUSION PROTEINS COMPRISING EUKARYOTIC CYTOCHROME P450 FUSED TO A REDUCTASE. UNIV TEXAS (US) 1997-03-19 — — EP claimed
EP-0649472-A1 FUSION PROTEINS COMPRISING EUKARYOTIC CYTOCHROME P450 FUSED TO A REDUCTASE THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1995-04-26 — — EP claimed
WO-1994001568-A1 FUSION PROTEINS COMPRISING EUKARYOTIC CYTOCHROME P450 FUSED TO A REDUCTASE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1994-01-20 — — WO claimed
WO-1992013076-A1 METHODS AND COMPOSITIONS FOR THE EXPRESSION OF BIOLOGICALLY ACTIVE EUKARYOTIC CYTOCHROME P450S IN BACTERIA BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1992-08-06 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044430-A1 Cosmetic composition containing a steroid and a 2-alkylalkanol or an ester thereof NOTUM, HSD3B2, HSD3B1 SHBG 7/4885CYP17A1 11/4885ALDH1A1 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.